Quality of Life results and survival outcomes in trials of immunotherapy in advanced cancers: a systematic review and meta-research study
{{output}}
Background: Benefit in Quality of Life (QoL) might be overlooked in trials investigating immunotherapy. We examined QoL results in phase III randomized controlled trials (RCTs) investigating immune checkpoint inhibitors (ICIs) in... ...
